Concepedia

Murilo Luz

ML

12

Publications

1.8K

Citations

12

H-Index

2014

Active since

Affiliations

Hospital Erasto Gaertner(Current)

Carolina Urologic Research Center

Pauls Stradiņš Clinical University Hospital

Lithuanian University of Health Sciences

Institut Gustave Roussy

Murilo Luz is an author at Hospital Erasto Gaertner specializing in medicine, urology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2014–2024

12

Publications

12

Darolutamide in Nonmetastatic, Castration-Resistant Prostate Cancer

Karim Fizazi, Neal D. Shore, Teuvo L.J. Tammela et al. · New England Journal of Medicine · 2019 · 890 citations · Full text

Nonmetastatic, Castration-Resistant Prostate Cancer and Survival with Darolutamide

Karim Fizazi, Neal D. Shore, Teuvo L.J. Tammela et al. · New England Journal of Medicine · 2020 · 341 citations · Full text

Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer

Stephen J. Freedland, Murilo Luz, Ugo De Giorgi et al. · New England Journal of Medicine · 2023 · 245 citations

Darolutamide in Combination With Androgen-Deprivation Therapy in Patients With Metastatic Hormone-Sensitive Prostate Cancer From the Phase III ARANOTE Trial

Fred Saad, Egils Vjaters, Neal D. Shore et al. · Journal of Clinical Oncology · 2024 · 102 citations · Full text

Overall survival (OS) results of phase III ARAMIS study of darolutamide (DARO) added to androgen deprivation therapy (ADT) for nonmetastatic castration-resistant prostate cancer (nmCRPC).

Karim Fizazi, Neal D. Shore, Teuvo L.J. Tammela et al. · Journal of Clinical Oncology · 2020 · 46 citations

, , +16

Rows per page

1–5 of 12